**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 646-20-8 |Heptanedinitrile | 98 | 211-469-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.The
toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be metabolized to cyanide which in
turn acts by inhibiting cytochrome oxidase impairing cellular
respiration.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Metabolism may release cyanide, which may result in headache,
dizziness, weakness, collapse, unconsciousness and possible death.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. May be
metabolized to cyanide which in turns act by inhibiting cytochrome
oxidase impairing cellular respiration.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Exposure should be treated as a cyanide poisoning. May be partially
metabolized to cyanide in the body.
Antidote:
Always have a cyanide antidote kit on hand when working with cyanide
compounds. Get medical advice to use.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Water may be ineffective.
Material is lighter than water and a fire may be spread by the use of
water. Vapors may be heavier than air. They can spread along the
ground and collect in low or confined areas. Containers may explode
when heated.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Cool containers with
flooding quantities of water until well after fire is out. Use water
spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective
Equipment section. Absorb spill using an absorbent, non-combustible
material such as earth, sand, or vermiculite. Do not use combustible
materials such as sawdust. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 646-20-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: aromatic odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 175 - 176 deg C @ 14.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9510g/cm3
Molecular Formula: C7H10N2
Molecular Weight: 122.17
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Strong acids, strong bases, strong oxidizing agents, strong reducing
agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 646-20-8: MI9020000
LD50/LC50:
CAS# 646-20-8: Oral, mouse: LD50 = 126 mg/kg.
Carcinogenicity:
Heptanedinitrile -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 646-20-8: No information available.
Canada
CAS# 646-20-8 is listed on Canada's DSL List.
CAS# 646-20-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 646-20-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ethyl delta-bromo-beta,beta-dimethyl levulinate, 96%
| 197234-17-6 |
|
1-Cyclohexyl-3-(2-Morpholinoethyl)Carbodiimide
| 2491-17-0 |
|
3-Chloroanisole, 99%
| 2845-89-8 |
|
2-Acetamidoacrylic acid, 99+ %
| 5429-56-1 |
|
Bianthrone
| 434-85-5 |
|
1-(4-Chlorophenyl)-1-cyclopentanecarbonyl chloride, 97%
| 71501-44-5 |
|
Acetic acid-d, 98 atom % d
| 758-12-3 |
|
n-Phenyl-1-naphthylamine, 98%
| 90-30-2 |
|
5-Methyl-2-Nitrobenzyl Chloride
| 66424-91-7 |
|
2-Hydroxy-4-Methoxybenzophenone, 98%
| 131-57-7 |
|
Myristyltrimethylammonium bromide, 99% (ti tr.)
| 1119-97-7 |
|
Cyclododecanone, 99+%
| 830-13-7 |
|
4,4'-Biphenol, 97%
| 92-88-6 |
|
Diphenylacetylene (Tolan), 99%
| 501-65-5 |
|
Dicyclohexyl Phenyl Phosphine
| 6476-37-5 |
|
(+/-)-2-azabicyclo2.2.1hept-5-en-3-one 98% (hplc)
| 49805-30-3 |
|
Iron (III) Sulfate Tetrahydrate, Reagent (Powder), 97% (Titr.)
| 15244-10-7 |
|
Phenyl Isocyanate (Pract), 98% (gc)
| 103-71-9 |
|
3,5-Dichlorosalicylaldehyde
| 90-60-8 |
|
1,5-Dicyanopentane, 98%
| 646-20-8 |
|
2-Pyridinecarboxaldehyde, 99%
| 1121-60-4 |
|
Lithium Iodide, Anhydrous, 99%
| 10377-51-2 |
|
Alginic Acid, Sodium Salt
| 9005-38-3 |
|
(2R,3R)-1-Carboxy-4,5-dichloro-2,3-dihydroxycyclohexa-4,6-diene
| 205587-32-2 |
|
4-Chloro-3-Nitrobenzoic Acid, 99.5%
| 96-99-1 |
|
Barium Titanate(iv), 99%
| 12047-27-7 |
|
2,3-Dichloro-5,6 Dicyano-1,4-Benzoquinone, 98%
| 84-58-2 |
|
Triethanolamine hydrochloride
| 637-39-8 |
|
2,6-Diisopropylaniline, 95%
| 24544-04-5 |
|
3-Quinuclidinol, 99%
| 1619-34-7 |
|
n,n-Dimethylformamide diethyl acetal, 98%
| 1188-33-6 |
|
(R)-4-Benzyl-2-oxazolidinone, 99%, (>99% e.e.)
| 102029-44-7 |
|
2-Ethylimidazole, 98%
| 1072-62-4 |
|
All-Trans-Retinoic Acid 97%
| 302-79-4 |
|
Bis(2-Ethylhexyl) Terephthalate, 98.5% (GC)
| 6422-86-2 |
|
D(+)-10-camphorsulfonic acid 99%
| 3144-16-9 |
|
1,6-Hexanedithiol, 97%
| 1191-43-1 |
|
Ferric benzoylacetonate
| 14323-17-2 |
|
3-Chlorophenyl isothiocyanate
| 2392-68-9 |
|
1-Bromodecane, 98%
| 112-29-8 |
|
Didodecyldimethylammonium bromide, 99%
| 3282-73-3 |
|
1,4-Cyclohexadiene, 97%
| 628-41-1 |
|
Dl-3-(alpha-acetonyl-4'-chlorobenzyl)- 4-hydroxycoumarin, 98%
| 81-82-3 |
|
3-Nitrophenol, 99%
| 554-84-7 |
|
O,O-Dimethyl-1-Hydroxy-2,2,2-Trichloroethylphosphonate, 98%
| 52-68-6 |
|
Allyl Chloride
| 107-05-1 |
|
1,2,3,4-Tetrahydroacridine-9-Carboxylic Acid Dihydrate
| 38186-54-8 |
|
1-Bromododecane, 98%
| 143-15-7 |
|
Ethyl 2,4-dioxovalerate, 98%
| 615-79-2 |
|
Arsenazo I, Indicator Grade
| 520-10-5 |
|
|